What Researchers Did
Researchers reported their 10-year experience treating 13 patients with radiation-induced hemorrhagic cystitis using hyperbaric oxygen therapy.
What They Found
Of the 13 patients with endoscopically or biopsy-proved hemorrhagic cystitis, 12 (92%) experienced durable cessation of hematuria. This positive outcome was achieved with minimal side effects, suggesting hyperbaric oxygen therapy is an effective treatment.
What This Means for Canadian Patients
Canadian patients suffering from radiation-induced hemorrhagic cystitis may find hyperbaric oxygen therapy to be a viable and effective treatment option. This therapy could offer lasting relief from hematuria with fewer side effects compared to other tissue-destructive treatments.
Canadian Relevance
This study has no direct Canadian connection as it was not conducted in Canada or by Canadian researchers.
Study Limitations
A key limitation of this study is its small sample size of 13 patients and the absence of a control group, which limits the generalizability of the findings.